Previous Article | Next Article 
Applied and Environmental Microbiology, November 2001, p. 5328-5330, Vol. 67, No. 11
Business Unit Cell Cybernetics, Plant
Research International B.V., 6700 AA Wageningen, The
Netherlands,2 and Department of Plant
Physiology and Molecular Biology, University of Plovdiv, Plovdiv,
Bulgaria1
Received 7 June 2001/Accepted 13 August 2001
Cry1 delta-endotoxins of Bacillus thuringiensis are
generally active against lepidopteran insects, but Cry1Ba and Cry1Ia
have additional, though low, levels of activity against coleopterans such as the Colorado potato beetle. Here we report the construction of
Cry1Ba/Cry1Ia hybrid toxins which have increased activities against
this insect species.
Bacillus
thuringiensis is a gram-positive bacterium which produces
insecticidal crystal (Cry) proteins during sporulation. The crystal
proteins form a large family of homologous, but different, proteins
with unique specificities. Each protein is active against only one or a
few insect species (for reviews, see references 6 and 20).
Proteins of the Cry3 (12, 17), Cry7 (14), and
Cry8 (19) classes are active against insects of the order
Coleoptera (beetles and weevils). Cry3Aa is the most active natural
protein for the important potato pest Leptinotarsa
decemlineata (Say) (Colorado potato beetle; CPB). Cry1 proteins
are generally active against lepidopterans. However, Cry1Ba and Cry1Ia
have been shown to also have activities against coleopterans, although
their toxicity for CPB is much lower than that of Cry3Aa (2,
21).
Cry proteins are formed as protoxins, which are activated by proteases
of the insect gut. This involves cleavage of an N-terminal peptide and,
in the larger Cry1 protoxins (but not in Cry3), of a C-terminal
extension. Structure determination by X-ray crystallography has shown
that the activated toxins of different, and probably most, Cry proteins
share a common three-domain structure (11, 16). N-terminal
domain I is thought to insert into the target membrane and form part of
the pores that eventually kill the target insect's gut epithelial
cells (20). Both domain II and C-terminal domain III are
more varied and have been shown to be main determinants of
activity against specific insects (1, 4, 9, 10). Although
it is not yet clear how these domains may individually or collectively
determine specificity, there is strong evidence that both can be
involved in binding to receptors (3, 4, 5, 8, 15).
Exchange of domain III between toxins, for example, by in vivo
recombination of their genes, may alter the specificity of a toxin
(1). Additionally, it may result in a hybrid toxin with a
toxicity for certain insects that is higher than that of its parent
toxins (7). So far, the latter phenomenon has been
described only for lepidopteran insects. In this paper, we show that
combination of parts of Cry1Ba and Cry1Ia results in hybrids with
increased activities against CPB, which is a coleopteran.
Expression vectors.
All used Cry protein expression vectors
are based on pBD12, a derivative of pKK233-2 (1). The
Cry1Ba expression vector pMH19 has been described previously
(9). The Cry1Ia expression vector pBD172 contains the full
cry1Ia gene with the SpeI site (nucleotide 2180)
fused to the SpeI site in the polylinker in pBD12, which is
derived from pBluescript SK(+). For Cry3Aa expression, the
cry3Aa gene was given an NcoI site at its start
by site-directed mutagenesis. An NcoI-XmnI
fragment (nucleotides 1 to 1935) was combined with an
XmnI-BglII linker, restoring the full coding region, and was used to replace the cry1Ab gene in the
expression vector pBD1400 (7), giving the Cry3Aa
expression vector pMH10.
Cry1Ia/Cry1Ba and Cry1Ba/Cry1Ia hybrids.
In order to be able
to directly exchange the domain III-encoding regions between
cry1Ba and cry1Ia, a new common restriction enzyme recognition site was made in both genes by site-directed mutagenesis. Complementary mutagenic oligonucleotide pairs were used to
create unique RsrII sites at positions 1464 and 1488 of cry1Ba(pMH19) and cry1Ia(pBD172), respectively,
using a QuickChange kit (Stratagene) without changing the encoded amino
acid sequences (Fig. 1A). Alignment of
the Cry1Ba and Cry1Ia amino acid sequences with that of Cry1Aa, for
which the three-dimensional structure has been established
(11), shows that this region in Cry1Aa is located in a
conserved region between the last beta strand of domain II (
0099-2240/01/$04.00+0 DOI: 10.1128/AEM.67.11.5328-5330.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
Bacillus thuringiensis Delta-Endotoxin
Cry1 Hybrid Proteins with Increased Activity against the Colorado
Potato Beetle
ABSTRACT
Top
Abstract
Text
References
TEXT
Top
Abstract
Text
References
11) and
the following beta strand of domain III (12). These unique
restriction sites allowed swapping of NcoI-RsrII fragments between pSN17 (cry1Ba) and pSN18
(cry1Ia). This resulted in plasmids pSN15 and pSN16,
encoding hybrids with the domain compositions 1Ia/1Ia/1Ba and
1Ba/1Ba/1Ia, respectively (Fig. 2). pSN19, encoding a hybrid with the domain composition 1Ba/1Ia/1Ba, was
made by replacing an NcoI-MunI (nucleotides 1 to
896) fragment encoding domain I of Cry1Ia in pSN15 by the corresponding
fragment encoding domain I of Cry1Ba (nucleotides 1 to 869) derived
from pSN16 (Fig. 1B). Alignment with the amino acid sequence and
structure of Cry1Aa (11) shows that this region of Cry1Aa
is located between beta strand 1a, which directly follows domain I
but is structurally a part of domain III, and the first beta strand of
domain II, 1b. Therefore, this step not only changes the entire
domain I into that of Cry1Ba but also completes domain III of Cry1Ba,
which in SN16 contains the area homologous to strand 1a derived from Cry1Ia.
View larger version (20K):
[in a new window]
FIG. 1.
(A) Oligonucleotides used to create RsrII
sites in the cry1Ba and cry1Ia genes by
mutagenesis and the amino acids encoded by the respective parts of the
genes. The two mutated nucleotides of the wild-type genes are shown
above and below the oligonucleotide sequences. (B) Localization of the
common MunI site in cry1Ba and cry1Ia
genes and the amino acids encoded by the respective parts of the
genes.
View larger version (26K):
[in a new window]
FIG. 2.
Domain compositions and insecticidal activities of
Cry1Ia/Cry1Ba hybrids and their parental protoxins. Bioassays were
performed with solubilized protoxins on potato leaves with neonate
CPBs. Concentrations (LC50s) are expressed as micrograms
per milliliter of dipping solution. Ninety-five percent fiducial limits
are shown in parentheses. ND, not determined. The column of data
labeled "Relative" gives toxicities relative to that of Cry3Aa on a
per-mole basis: (molecular weight of protein/molecular weight of
Cry3Aa) × (LC50 of Cry3Aa/LC50 of
protein) × 100.
Protein isolation and insect bioassays. For large-scale production, all parental and hybrid protoxins were expressed in E. coli strain XL-1, extracted, and solubilized as described previously (1). Solubilized protoxins were dialyzed overnight against 25 mM NaHCO3-100 mM NaCl, pH 10. Protein concentrations were estimated in duplicate by sodium dodecyl sulfate-polyacrylamide gel electrophoresis using a standard curve of bovine serum albumin. To test toxicity to CPB, leaflets of greenhouse-grown potato cultivar Desiree plants were dipped in protoxin dilutions in water containing 0.01% Tween 20. After air drying of the leaves, they were transferred to petri dishes and 10 neonate CPB larvae were placed on each leaf. After incubation for 2 days at room temperature, the leaves were replaced by fresh leaves dipped in identical protoxin dilutions. Mortality was scored after 4 days. Cry3Aa was analyzed as a positive control and for comparison. Fifty percent lethal concentrations (LC50s) and 95% fiducial limits were determined by Probit analysis of results from three or more independent experiments using the PoloPC computer program (18). Results of bioassays are shown in Fig. 2.
Cry1Ba/Cry1Ia hybrid protein SN16 had very low toxicity against CPB, and not enough protoxin was purified to determine a reliable LC50. Surprisingly, the Cry1Ia/Cry1Ba hybrid SN15 was more toxic than both of the parent proteins. When the size differences are taken into consideration, SN15 is potentially 2.5 times more toxic than Cry1Ia and 7.5 times more toxic than Cry1Ba on a per-mole basis. This finding indicates that domain I or II of Cry1Ia or both domains are important determinants of the higher activity of Cry1Ia relative to that of Cry1Ba. However, the combination with domain III and the protoxin-specific C-terminal part of Cry1Ba renders the resulting hybrid even more toxic than Cry1Ia. We therefore conclude that, also for coleopterans, hybrid toxins resulting from domain swapping may have improved properties, as was shown earlier to be the case for lepidopterans. The additional domain I substitution giving a mosaic 1Ba/1Ia/1Ba hybrid (SN19) increased toxicity even further, resulting in activity approaching that of Cry3Aa against CPB. This result not only identifies Cry1Ia domain II, and not domain I, as its most important determinant for activity against CPB but also emphasizes the point that new domain combinations may result in higher activity. New combinations of the receptor binding domains II and III resulted in increased activities of hybrids for several lepidopterans (7, 10). The molecular mechanisms underlying this effect are not well understood, although studies of Cry1Ac binding to a putative receptor, Lymantria dispar aminopeptidase N, suggested that domain II and domain III confer two separate steps in binding to this protein in a two-step model and that one step may be rate limiting for that binding (13). Following this line of reasoning, one could speculate that both Cry1Ba and Cry1Ia bind to the same receptor in CPBs but that different steps are rate limiting for the 2 toxins. Hence, the proper combination of domains II and III may optimize both binding steps and thus increase activity. Furthermore, the combination of these domains with domain I of Cry1Ba is more active. Since both Cry1Ba and SN19 have extended protoxin-specific C-termini compared to that of Cry1Ia, the possibility of a role of these extensions in the higher toxicity of SN19 cannot yet be excluded. This, however, would be contrary to the findings of Lambert et al. for Cry7Aa, which was found to be active against CPB only after solubilization and activation (14). In this study we have tested solubilized protoxins, while it was shown earlier for Cry1Ba that solubilization prior to testing was necessary for high activity against CPB (2). This need may be caused by the relatively low gut pH (pH 6 to 7) in CPB, compared to that in lepidopterans, which inhibits solubilization of the crystalline protoxin. Whether this inhibition would prevent effective application of SN19 in a crystalline form and whether SN19 may be an alternative for Cry3Aa in CPB-resistant transgenic plants are the subjects of our further studies.| |
FOOTNOTES |
|---|
* Corresponding author. Mailing address: Business Unit Cell Cybernetics, Plant Research International B.V., P.O. Box 16, 6700 AA Wageningen, The Netherlands. Phone: 31(317) 477128. Fax: 31(317) 418094. E-mail: R.A.deMaagd{at}plant.wag-ur.nl.
| |
REFERENCES |
|---|
|
Top
Abstract
Text
References
|
|---|
| 1. | Bosch, D., B. Schipper, H. van der Kleij, R. de Maagd, and W. Stiekema. 1994. Recombinant Bacillus thuringiensis crystal proteins with new properties: possibilities for resistance management. Bio/Technology 12:915-918[CrossRef][Medline]. |
| 2. | Bradley, D., M. A. Harkey, M. K. Kim, K. D. Biever, and L. S. Bauer. 1995. The insecticidal CryIB crystal protein of Bacillus thuringiensis ssp. thuringiensis has dual specificity to coleopteran and lepidopteran larvae. J. Invertebr. Pathol. 65:162-173[CrossRef][Medline]. |
| 3. | Burton, S. L., D. J. Ellar, J. Li, and D. J. Derbyshire. 1999. N-Acetylgalactosamine on the putative insect receptor aminopeptidase N is recognised by a site on the domain III lectin-like fold of a Bacillus thuringiensis insecticidal toxin. J. Mol. Biol. 287:1011-1022[CrossRef][Medline]. |
| 4. |
Dean, D. H.,
F. Rajamohan,
M. K. Lee,
S. J. Wu,
X. J. Chen,
E. Alcantara, and S. R. Hussain.
1996.
Probing the mechanism of action of Bacillus thuringiensis insecticidal proteins by site-directed mutagenesis a minireview.
Gene
179:111-117[CrossRef][Medline].
|
| 5. | de Maagd, R. A., P. L. Bakker, L. Masson, M. J. Adang, S. Sangadala, W. Stiekema, and D. Bosch. 1999. Domain III of the Bacillus thuringiensis delta-endotoxin Cry1Ac is involved in binding to Manduca sexta brush border membranes and to its purified aminopeptidase N. Mol. Microbiol. 31:463-471[CrossRef][Medline]. |
| 6. | de Maagd, R. A., A. Bravo, and N. Crickmore. 2001. How Bacillus thuringiensis has evolved specific toxins to colonize the insect world. Trends Genet. 17:193-199[CrossRef][Medline]. |
| 7. | de Maagd, R. A., M. S. G. Kwa, H. van der Klei, T. Yamamoto, B. Schipper, J. M. Vlak, W. J. Stiekema, and D. Bosch. 1996. Domain III substitution in Bacillus thuringiensis delta-endotoxin CryIA(b) results in superior toxicity for Spodoptera exigua and altered membrane protein recognition. Appl. Environ. Microbiol. 62:1537-1543[Abstract]. |
| 8. |
de Maagd, R. A.,
H. van der Klei,
P. L. Bakker,
W. J. Stiekema, and D. Bosch.
1996.
Different domains of Bacillus thuringiensis  -endotoxins can bind to insect midgut membrane proteins on ligand blots.
Appl. Environ. Microbiol.
62:2753-2757[Abstract].
|
| 9. |
de Maagd, R. A.,
M. Weemen-Hendriks,
W. Stiekema, and D. Bosch.
2000.
Bacillus thuringiensis delta-endotoxin Cry1C domain III can function as a specificity determinant for Spodoptera exigua in different, but not all, Cry1-Cry1C hybrids.
Appl. Environ. Microbiol.
66:1559-1563 |
| 10. |
Ge, A. Z.,
D. Rivers,
R. Milne, and D. H. Dean.
1991.
Functional domains of Bacillus thuringiensis insecticidal crystal proteins. Refinement of Heliothis virescens and Trichoplusia ni specificity domains on CryIA (c).
J. Biol. Chem.
266:17954-17958 |
| 11. | Grochulski, P., L. Masson, S. Borisova, M. Pusztai-Carey, J. L. Schwartz, R. Brousseau, and M. Cygler. 1995. Bacillus thuringiensis CryIA(a) insecticidal toxin-crystal structure and channel formation. J. Mol. Biol. 254:447-464[CrossRef][Medline]. |
| 12. | Herrnstadt, C., G. G. Soares, E. R. Wilcox, and D. L. Edwards. 1986. A new strain of Bacillus thuringiensis with activity against coleopteran insects. Bio/Technology 4:305-308[CrossRef]. |
| 13. |
Jenkins, J. L.,
M. K. Lee,
A. P. Valaitis,
A. Curtiss, and D. H. Dean.
2000.
Bivalent sequential binding model of a Bacillus thuringiensis toxin to gypsy moth aminopeptidase N receptor.
J. Biol. Chem.
275:14423-14431 |
| 14. |
Lambert, B.,
H. Höfte,
K. Annys,
S. Jansens,
P. Soetaert, and M. Peferoen.
1992.
Novel Bacillus thuringiensis insecticidal crystal protein with a silent activity against coleopteran larvae.
Appl. Environ. Microbiol.
58:2536-2542 |
| 15. | Lee, M. K., B. A. Young, and D. H. Dean. 1995. Domain III exchanges of Bacillus thuringiensis CryIA toxins affect binding to different gyspy moth midgut receptors. Biochem. Biophys. Res. Commun. 216:306-312[CrossRef][Medline]. |
| 16. | Li, J., J. Carroll, and D. J. Ellar. 1991. Crystal structure of insecticidal delta-endotoxin from Bacillus thuringiensis at 2.5 Å resolution. Nature 353:815-821[CrossRef][Medline]. |
| 17. | McPherson, S., F. Perlak, R. Fuchs, P. Marrone, P. Lavrik, and D. Fischhoff. 1988. Characterization of the coleopteran-specific protein gene of Bacillus thuringiensis var. tenebrionis. Bio/Technology 6:61-66. |
| 18. | Russel, R. M., J. L. Robertson, and N. E. Savin. 1977. POLO: a new computer program for Probit analysis. ESA Bull. 23:209-213. |
| 19. | Sato, R., K. Takeuchi, K. Ogiwara, M. Minami, Y. Kaji, N. Suzuki, H. Hori, S. Asano, M. Ohba, and H. Iwahana. 1994. Cloning, heterologous expression, and localization of a novel crystal protein gene from Bacillus thuringiensis serovar japonensis strain buibui toxic to scarabaeid insects. Curr. Microbiol. 28:15-19[CrossRef][Medline]. |
| 20. |
Schnepf, E.,
N. Crickmore,
J. Van Rie,
D. Lereclus,
J. Baum,
J. Feitelson,
D. R. Zeigler, and D. H. Dean.
1998.
Bacillus thuringiensis and its pesticidal crystal proteins.
Microbiol. Mol. Biol. Rev.
62:775-806 |
| 21. | Tailor, R., J. Tippet, G. Gibb, S. Pells, D. Pike, L. Jordan, and S. Ely. 1992. Identification and characterization of a novel Bacillus thuringiensis delta-endotoxin entomocidal to coleopteran and lepidopteran larvae. Mol. Microbiol. 6:1211-1217[CrossRef][Medline]. |
Applied and Environmental Microbiology, November 2001, p. 5328-5330, Vol. 67, No. 11
0099-2240/01/$04.00+0 DOI: 10.1128/AEM.67.11.5328-5330.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Naimov, S., Boncheva, R., Karlova, R., Dukiandjiev, S., Minkov, I., de Maagd, R. A.
(2008). Solubilization, Activation, and Insecticidal Activity of Bacillus thuringiensis Serovar thompsoni HD542 Crystal Proteins. Appl. Environ. Microbiol.
74: 7145-7151
[Abstract] [Full Text] -
Fang, J., Xu, X., Wang, P., Zhao, J.-Z., Shelton, A. M., Cheng, J., Feng, M.-G., Shen, Z.
(2007). Characterization of Chimeric Bacillus thuringiensis Vip3 Toxins. Appl. Environ. Microbiol.
73: 956-961
[Abstract] [Full Text] -
Cappello, M., Bungiro, R. D., Harrison, L. M., Bischof, L. J., Griffitts, J. S., Barrows, B. D., Aroian, R. V.
(2006). A purified Bacillus thuringiensis crystal protein with therapeutic activity against the hookworm parasite Ancylostoma ceylanicum. Proc. Natl. Acad. Sci. USA
103: 15154-15159
[Abstract] [Full Text]
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»